![Alan D. Cainey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alan D. Cainey
Directeur Financier/CFO chez
Bioscience Managers Pty Ltd.
Profil
Mr. Alan D.
Cainey is a Chief Financial Officer & Senior Partner at Bioscience Managers Pty Ltd.
Mr. Cainey was previously employed as a Chief Financial Officer by Octa Phillip Resources Management Pty Ltd.
He received his graduate degree from the University of the West of England.
Postes actifs de Alan D. Cainey
| Sociétés | Poste | Début |
|---|---|---|
Bioscience Managers Pty Ltd.
 Bioscience Managers Pty Ltd. Investment ManagersFinance Bioscience Managers invests in both public and private companies located in Asia, Australia and New Zealand. The firm focuses on healthcare and life sciences sectors. It participates in early and growth stage capital transactions. | Directeur Financier/CFO | - |
Anciens postes connus de Alan D. Cainey
| Sociétés | Poste | Fin |
|---|---|---|
Octa Phillip Resources Management Pty Ltd.
 Octa Phillip Resources Management Pty Ltd. Investment ManagersFinance Provides investment advice | Directeur Financier/CFO | - |
Formation de Alan D. Cainey
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
9
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
University of the West of England
 University of the West of England Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Octa Phillip Resources Management Pty Ltd.
Octa Phillip Resources Management Pty Ltd. Investment ManagersFinance Provides investment advice | Finance |
Bioscience Managers Pty Ltd.
Bioscience Managers Pty Ltd. Investment ManagersFinance Bioscience Managers invests in both public and private companies located in Asia, Australia and New Zealand. The firm focuses on healthcare and life sciences sectors. It participates in early and growth stage capital transactions. | Finance |
Choisissez Zonebourse 
